Biomarin Pharmaceutical Inc
XMUN:BM8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
A
|
Alphabet Inc
F:ABEA
|
US |
|
Unicharm Corp
F:UN41
|
JP |
|
F
|
Fresenius Medical Care AG & Co KGaA
XHAM:FME
|
DE |
|
K
|
Klepierre SA
SWB:KPR
|
FR |
|
Societe Generale SA
PAR:GLE
|
FR |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
S
|
Swire Pacific Ltd
HKEX:87
|
HK |
|
China Shenhua Energy Co Ltd
F:IKF
|
CN |
|
Celestica Inc
TSX:CLS
|
CA |
|
Koninklijke BAM Groep NV
AEX:BAMNB
|
NL |
|
S
|
Sumitomo Mitsui Financial Group Inc
DUS:XMF
|
JP |
|
Canon Electronics Inc
TSE:7739
|
JP |
|
N
|
NIO Inc
LSE:0A1K
|
CN |
|
V
|
Vingroup JSC
VN:VIC
|
VN |
|
C
|
Cal-Maine Foods Inc
F:CM2
|
US |
|
S
|
Steel Dynamics Inc
XMUN:SD5
|
US |
|
E
|
Element Solutions Inc
F:PLQ
|
US |
|
I
|
IAMGOLD Corp
XBER:IAL
|
CA |
|
United Utilities Group PLC
LSE:UU
|
UK |
|
Tenaris SA
NYSE:TS
|
LU |
|
B
|
Bankinter SA
XBER:BAKA
|
ES |
|
Kronos Worldwide Inc
NYSE:KRO
|
US |
Multiples-Based Value
The Multiples-Based Value for
Biomarin Pharmaceutical Inc (BM8) under the Base Case is hidden
EUR.
Compared with the current market price of 56.11 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.